Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | PCNA | P12004 | 4/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | MDM4 | O15151 | 1/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CHRND | Q07001 | 5/20 | 0.43 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.43 |
| ▸ | CHRNG | P07510 | 1/20 | 0.43 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13123764 | 1.00 | ALDH1A1 (0.48) | ALDH1A1PCNANPSR1BACE1MDM4 | |
| SCHEMBL24091032 | 0.97 | ALDH1A1 (0.46) | ALDH1A1PCNANPSR1BACE1MDM4 | |
| SCHEMBL24091040 | 0.95 | PCNA (0.54) | ALDH1A1PCNANPSR1BACE1MDM4 | |
| SCHEMBL13938296 | 0.91 | ALDH1A1 (0.46) | ALDH1A1PCNANPSR1BACE1MDM4 | |
| SCHEMBL21884113 | 0.91 | ALDH1A1 (0.46) | ALDH1A1PCNANPSR1BACE1MDM4 | |
| SCHEMBL29352083 | 0.90 | ALDH1A1 (0.50) | ALDH1A1NPSR1BACE1MDM4MDM2 | |
| SCHEMBL21466071 | 0.90 | ALDH1A1 (0.50) | ALDH1A1NPSR1BACE1MDM4MDM2 | |
| SCHEMBL4403610 | 0.90 | BACE1 (0.43) | ALDH1A1PCNANPSR1BACE1MDM4 | |
| SCHEMBL16021248 | 0.90 | FOLH1 (0.47) | ALDH1A1PCNAPOLB | |
| Bicarbonate SCHEMBL30452528 | 0.88 | MDM4 (0.51) | ALDH1A1NPSR1BACE1MDM4MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240301134-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240301134-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | TH, TYR, MYB | ALDH1A1 2408/4885PCNA 527/4885NPSR1 1077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.